Comparison of Simoa TM and Ella TM to assess serum neurofilament-light chain in multiple sclerosis

We compared Simoa and Ella immunoassays to assess serum neurofilament-light chain levels in 203 multiple sclerosis patients from the OFSEP HD study. There was a strong correlation (ρ = 0.86, p 

Saved in:
Bibliographic Details
Published in:Annals of clinical and translational neurology 2021-05, Vol.8 (5), p.1141-1150
Main Authors: Gauthier, Audrey, Viel, Sébastien, Perret, Magali, Brocard, Guillaume, Casey, Romain, Lombard, Christine, Laurent-Chabalier, Sabine, Debouverie, Marc, Edan, Gilles, Vukusic, Sandra, Lebrun-Frénay, Christine, De Sèze, Jérôme, Laplaud, David Axel, Castelnovo, Giovanni, Gout, Olivier, Ruet, Aurélie, Moreau, Thibault, Casez, Olivier, Clavelou, Pierre, Berger, Eric, Zephir, Hélène, Trouillet-Assant, Sophie, Thouvenot, Eric
Format: Article
Language:English
Subjects:
Age
Agreements
Biomarkers
Humans
Immunoassay - standards
Multiple sclerosis
Multiple Sclerosis - blood
Multiple Sclerosis - diagnosis
Neurofilament Proteins - blood
Patients
Regression analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We compared Simoa and Ella immunoassays to assess serum neurofilament-light chain levels in 203 multiple sclerosis patients from the OFSEP HD study. There was a strong correlation (ρ = 0.86, p 
ISSN:2328-9503
2328-9503
DOI:10.1002/acn3.51355